CUVL · Ratios · TradingHolo

Markets › United States › NAS › CUVL

Clinuvel Pharmaceuticals Ltd.

NAS:CUVLHealthcarenasdaq_composite

$5.19−0.95%At closeAt close · Tue 20 Oct · ≈ AED 19.06 · Market cap $262.51M · Next earnings Tue 23 Feb

🔔 Alert▶ Test a strategy

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Trend	YoY
Gross margin	73.4%	70.9%	64.6%	65.7%	65.8%	83.2%		+17.4 pts
Operating margin	55.6%	50.3%	52.2%	49.4%	43.5%	43.2%		−0.3 pts
Net margin	51.5%	31.8%	39.1%	40.4%	38.1%	36.1%		−2.0 pts
EBITDA margin	57.4%	51.5%	53.2%	50.7%	44.7%	44.2%		−0.5 pts
Return on equity	24.9%	17.5%	18.8%	17.2%	14.8%	12.2%		−2.7 pts
Return on assets	22.6%	15.2%	15.9%	15.1%	13.1%	11.2%		−1.9 pts
Return on capital employed	26.6%	26.6%	24.5%	20.7%	16.6%	14.3%		−2.3 pts
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×		+223.7%
Debt / assets	1.2%	0.9%	0.5%	0.4%	0.2%	0.7%		+0.5 pts
Interest coverage	0.0×	0.0×	0.0×	1,048.9×	1,042.9×	499.7×		−52.1%
Current ratio	11.8×	10.2×	7.4×	8.8×	9.7×	14.8×		+53.3%
Quick ratio	11.4×	10.1×	7.1×	8.4×	9.3×	14.5×		+54.8%
Cash ratio	4.3×	2.0×	0.9×	1.4×	1.0×	1.1×		+3.3%
Asset turnover	0.4×	0.5×	0.4×	0.4×	0.3×	0.3×		−9.8%
Inventory turnover	4.0×	11.0×	2.9×	2.8×	3.6×	2.2×		−38.3%
Receivables turnover	3.0×	4.3×	3.6×	3.3×	3.4×	3.9×		+14.7%
Dividend payout	5.0%	5.9%	6.5%	6.9%	6.9%	7.4%		+0.5 pts

Margins, returns, leverage and liquidityUpdated Tue 30 Jun ·

ⓘ